Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Microbiome Company is a biotechnology firm focused on harnessing the power of the human microbiome to develop novel therapeutic and diagnostic solutions. The company utilizes advanced sequencing and bioinformatics to analyze microbial communities and their impact on human health, particularly in the context of gastrointestinal and metabolic conditions. By identifying specific microbial signatures associated with disease, they aim to create targeted live biotherapeutic products and precision diagnostics. Their approach integrates clinical data with microbiome profiling to provide a comprehensive understanding of host-microbe interactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Microbiome Company.